<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
CMND
Clearmind Medicine
$
()


  • Clearmind Medicine enters licensing agreement with Yissum Research

    4/17/2024 - 07:53am
  • Here's What You Missed in Cannabis, Psychedelics This Week

    4/11/2024 - 10:24am
  • Clearmind files U.S. patent application for psychedelic-based treatment

    4/10/2024 - 07:20am
  • Clearmind CEO says poised to achieve 'significant milestones' through 2024

    4/9/2024 - 08:38am
  • Here's What You Missed in Cannabis, Psychedelics This Week

    4/4/2024 - 11:06am
  • Clearmind Medicine announces international patent application on depression

    3/27/2024 - 09:14am
  • SciSparc says Clearmind submits international patent application for depression

    3/27/2024 - 08:56am
  • Here's What You Missed in Cannabis, Psychedelics This Week

    3/21/2024 - 10:52am
  • Clearmind Medicine granted divisional patent approval in China

    3/19/2024 - 07:58am
  • Rising High: Exclusive talk with cannabis market research firm BDSA

    3/14/2024 - 11:15am
  • Clearmind Medicine obtains clearance for Phase I/IIa trial in AUD

    3/13/2024 - 08:34am
  • Clearmind Medicine receives approval for voluntary delisting from CSE

    3/13/2024 - 07:34am
  • Rising High: Exclusive talk with multi-state operator C3 Industries

    3/7/2024 - 13:09pm
  • Rising High: Exclusive talk with vape tech developer Ispire Technology

    3/7/2024 - 10:46am
  • Clearmind Medicine submits three additional international patent applications

    2/27/2024 - 08:02am
dynamic_feed Breaking News